Home
Conditions
Disease Progression

Clinical trial condition

Disease Progression

Explore clinical trials studying Disease Progression. Study availability and eligibility vary by location and protocol.

281 public trials 63 recruiting studies

Refine in advanced search Browse all conditions

Disease Progression trial results

Active, not recruiting

Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia

NCT06538441

Conditions: Disease Attributes, Disease Progression, Infections, +7 more
Locations: Mei Kang Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

NCT03422393

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

View Trial Details

Active, not recruiting

Prospective Observational Study of Disease Progression in Chronic Hepatitis C

NCT02011932

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

Propionic Acid in Multiple Sclerosis

NCT06402487

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations: Salzburger Landeskliniken Salzburg, State of Salzburg, Austria

View Trial Details

Completed

Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study

NCT07798479

Conditions: Bladder Cancer, Carcinoma, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Completed

Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge

NCT06941753

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +11 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III

NCT02761070

Conditions: Astrocytoma, Disease Attributes, Disease Progression, +13 more
Locations: Nagoya University Hospital Nagoya, Aichi-ken, Japan

Fujita Health University Hospital Toyoake, Aichi-ken, Japan

Hirosaki University School of Medicine Hirosaki, Aomori, Japan

Chiba University Hospital Chiba, Japan

View all 37 locations

View Trial Details

Completed

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT03586661

Conditions: Adnexal Diseases, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, +32 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

NCT03374332

Conditions: Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
Locations: Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Completed

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

NCT04617743

Conditions: Bladder Cancer Recurrent, Carcinoma, Disease Attributes, +19 more
Locations: Health Sciences University, Dıskapi Yildirim Beyazit Training and Research Hospital Ankara, Turkey (Türkiye)

Istanbul Medeniyet University Istanbul, Turkey (Türkiye)

Health Sciences University, Tepecik Training and Research Hospital Izmir, Turkey (Türkiye)

View Trial Details

Disease Progression

Disease Progression trial results

Related conditions